Ftse Mib
34.204,33
-0,50%
DAX
18.495,83
-0,56%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.189,39
-2,57%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
16/05/201614:00PR Newswire (US)BioPharmX Presents at American Congress of Obstetricians and Gynecologists (ACOG) Suggesting Molecular Iodine May be Effectiv...AMEX:BPMXBioPharmX Corporation
12/05/201623:16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
12/05/201622:15PR Newswire (US)BioPharmX CEO Steps Down, Board Appoints Independent Director to Serve as ChairmanAMEX:BPMXBioPharmX Corporation
09/05/201613:00PR Newswire (US)BioPharmX to Present Research at Vitafoods Europe Showing that Molecular Iodine is Key to the Healthy Aging of Women's Breast...AMEX:BPMXBioPharmX Corporation
02/05/201622:11Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
26/04/201622:10PR Newswire (US)BioPharmX Corporation Reports Fourth Quarter and Fiscal Year End Financial ResultsAMEX:BPMXBioPharmX Corporation
25/04/201614:00PR Newswire (US)BioPharmX Announces Full Patient Enrollment in Phase 2a Study of BPX-01 Topical Antibiotic for AcneAMEX:BPMXBioPharmX Corporation
13/04/201614:00PR Newswire (US)BioPharmX to Report Fourth Quarter and Full Year Financial Results on April 26, 2016AMEX:BPMXBioPharmX Corporation
04/04/201614:30PR Newswire (Canada)Health Canada Approves BioPharmX Corporation Study of Violet® IodineAMEX:BPMXBioPharmX Corporation
01/04/201617:45PR Newswire (US)BioPharmX Corporation Announces Closing Of $4.3 Million Public OfferingAMEX:BPMXBioPharmX Corporation
01/04/201601:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
30/03/201622:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
29/03/201615:16PR Newswire (US)BioPharmX Corporation Announces Pricing Of Public Offering To Raise $4.3 MillionAMEX:BPMXBioPharmX Corporation
28/03/201622:05PR Newswire (US)BioPharmX Corporation Announces Proposed Public Offering of Common Stock and WarrantsAMEX:BPMXBioPharmX Corporation
22/03/201613:00PR Newswire (US)BioPharmX Corporation Initiates Post-Market Phase IV Study for Fibrocystic Breast Condition (FBC) and Cyclic MastalgiaAMEX:BPMXBioPharmX Corporation
03/03/201615:00PR Newswire (US)BioPharmX commences Phase 2 clinical study under U.S. FDA IND for BPX-01AMEX:BPMXBioPharmX Corporation
25/02/201618:30PR Newswire (US)BioPharmX Announces Therapeutic Dermatology Advisory BoardAMEX:BPMXBioPharmX Corporation
16/02/201615:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
05/02/201612:02Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
01/02/201615:00PR Newswire (US)BioPharmX Appoints Marie-Louise Bots as Senior VP of Corporate DevelopmentAMEX:BPMXBioPharmX Corporation
27/01/201620:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:BPMXBioPharmX Corporation
27/01/201615:00PR Newswire (US)BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of DirectorsAMEX:BPMXBioPharmX Corporation
19/01/201614:32Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
15/01/201615:00PR Newswire (US)Study Shows Topical BioPharmX Formulation Treats Acne While Minimizing Systemic Exposure of MinocyclineAMEX:BPMXBioPharmX Corporation
12/01/201614:00PR Newswire (US)BioPharmX Violet Iodine Mobile Marketing Campaign On Pandora Achieves 25 Times the Average Industry ResponseAMEX:BPMXBioPharmX Corporation
21/12/201519:41Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:BPMXBioPharmX Corporation
15/12/201519:04Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
14/12/201522:05PR Newswire (US)BioPharmX Corporation Reports Third Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
11/12/201515:00PR Newswire (US)BioPharmX Corporation to Report Third Quarter Financial Results on December 14, 2015AMEX:BPMXBioPharmX Corporation
11/12/201514:00PR Newswire (US)Study Shows Safety of BioPharmX Topical FormulationAMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

LSE
PPHP
Papillon
BOV
CSNA3
SID NACIONAL ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network